Distribution of doxorubicin in the bladder wall and regional lymph nodes after bladder submucosal injection of liposomal doxorubicin in the dog

Journal of Urology

Volumn 161, Issue 2, 1999, Pages 665-667

  Kiyokawa, Hideo ^a   Igawa, Yasuhiko ^a   Muraishi, Osamu ^a   Katsuyama, Yoshihiko ^a   Iizuka, Keiji ^a   Nishizawa, Osamu ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dog bladder; Liposomal doxorubicin; Lymph nodes; Submucosal injection

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; DRUG CARRIER; LIPOSOME;

ANIMAL; ARTICLE; BLADDER; DOG; FEMALE; LYMPH NODE; METABOLISM; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS; DOGS; DOXORUBICIN; DRUG CARRIERS; FEMALE; LIPOSOMES; LYMPH NODES; TISSUE DISTRIBUTION; URINARY BLADDER;

EID: 0033074411     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)61991-8     Document Type: Article

References (13)

1. Olson, F., Mayhew, E., Maslow, D., Rustum, Y. and Szoka, F.: Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes. Eur. J. Cancer Clin. Oncol., 18: 167, 1982.
2. Huang, S. K., Lee, K. D., Hong, K., Friend, D. S. and Papahadjopoulos, D.: Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res., 52: 5135, 1992.
3. Vaage, J., Donovan, D., Mayhew, E., Abra, R. and Huang, A.: Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes. Cancer, 72: 3671, 1993.
4. Vaage, J., Donovan, D., Loftus, T., Abra, R., Working, P. and Huang, A.: Chemoprevention and therapy of mouse mammary carcinomas with doxorubicin encapsulated in sterically stabilized liposomes. Cancer, 73: 2366, 1993.
5. Vaage, J., Guillem, E. B., Abra, R., Huang, A. and Working, P.: Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts. Cancer, 73: 1478, 1993.
6. Yagoda, A.: Chemotherapy of metastatic bladder cancer. Cancer, 45: 1879, 1980.
7. Mayer, L. D., Tai, L. C. L., Bally, M. B., Mitilenes, G. N., Ginsberg, R. S. and Cullis, P. R.: Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim. Biophys. Acta, 1025: 143, 1990.
8. Masue, T., Odake, J., Kohagura, M., Noda, T. and Takemoto, Y.: Determination of adriamycin and its metabolites in biological samples using high performance liquid chromatography: Analysis of tissue by extraction method. Yakugaku Zasshi, 104: 620, 1984.
9. O'Bryan, R. M., Baker, L. H., Gottlieb, J. E., Rivkin, S. E., Balcerzak, S. P., Grumet, G. N., Salmon, S. E., Moon, T. E. and Hoogstraten, B.: Dose response evaluation of adriamycin in human neoplasia. Cancer, 39: 1940, 1977.
10. Lerner, S. P., Skinner, E. and Skinner, D. G.: Radical cystectomy in regionally advanced bladder cancer. Urol. Clin. North Am., 19: 713, 1992.
11. Sarosdy, M. F., Lamm, D. L., Radwin, H. M. and Hoff, D. D.: Clonogenic assay and in vitro chemosensitivity testing of human urologic malignancies. Cancer, 50: 1332, 1982.
12. Egerdie, R. B., Reid, G. and Trachtenberg, J.: The effect of liposome encapsulated antineoplastic agents on transitional cell carcinoma in tissue culture. J. Urol., 142: 390, 1989.
13. Tsuruta, T., Muraishi, O., Katsuyama, Y., Murata, Y., Ichino, M. and Ogawa, A.: Liposome encapsulated doxorubicin transfer to the pelvic lymph nodes by endoscopic administration into the bladder wall: a preliminary report. J. Urol., 157: 1652, 1997.